| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Paradigm Biopharmaceuticals Limited (AU: PAR)
PAR Technical Analysis
5
| As on 22nd Nov 2024 PAR STOCK Price closed @ 0.32 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.54 & Strong Sell for SHORT-TERM with Stoploss of 0.90 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PARSTOCK Price
| Open | 0.28 | Change | Price | % |
| High | 0.34 | 1 Day | 0.05 | 18.52 |
| Low | 0.28 | 1 Week | 0.08 | 33.33 |
| Close | 0.32 | 1 Month | 0.11 | 52.38 |
| Volume | 4323340 | 1 Year | -0.57 | -64.04 |
| 52 Week High 1.05 | 52 Week Low 0.18 | ||||
AU Australia Most Active Stocks
| OVT | 0.02 | % |
| SYA | 0.03 | 0.00% |
| PLS | 2.61 | -6.79% |
| TMK | 0.00 | % |
| ROG | 0.01 | 0.00% |
| FAU | 0.00 | % |
| FFG | 0.02 | 0.00% |
| RSG | 0.40 | 0.00% |
| PEN | 0.06 | 0.00% |
| IMU | 0.04 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| PAR Daily Charts |
PAR Intraday Charts |
Whats New @ Bazaartrend |
PAR Free Analysis |
|
|
PAR Important Levels Intraday
| RESISTANCE | 0.44 |
| RESISTANCE | 0.40 |
| RESISTANCE | 0.38 |
| RESISTANCE | 0.35 |
| SUPPORT | 0.29 |
| SUPPORT | 0.26 |
| SUPPORT | 0.24 |
| SUPPORT | 0.20 |
PAR Forecast November 2024
| 4th UP Forecast | 1.13 |
| 3rd UP Forecast | 0.87 |
| 2nd UP Forecast | 0.71 |
| 1st UP Forecast | 0.55 |
| 1st DOWN Forecast | 0.09 |
| 2nd DOWN Forecast | -0.07 |
| 3rd DOWN Forecast | -0.23 |
| 4th DOWN Forecast | -0.49 |
PAR Weekly Forecast
| 4th UP Forecast | 0.72 |
| 3rd UP Forecast | 0.59 |
| 2nd UP Forecast | 0.51 |
| 1st UP Forecast | 0.43 |
| 1st DOWN Forecast | 0.21 |
| 2nd DOWN Forecast | 0.13 |
| 3rd DOWN Forecast | 0.05 |
| 4th DOWN Forecast | -0.08 |
PAR Forecast2024
| 4th UP Forecast | 2.11 |
| 3rd UP Forecast | 1.54 |
| 2nd UP Forecast | 1.18 |
| 1st UP Forecast | 0.83 |
| 1st DOWN Forecast | -0.19 |
| 2nd DOWN Forecast | -0.54 |
| 3rd DOWN Forecast | -0.9 |
| 4th DOWN Forecast | -1.47 |
Paradigm Biopharmaceuticals Limited ( AU Australia Symbol : PAR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PAR Business Profile
Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable form for the treatment of bone marrow edema lesions, osteoarthritis, mucopolysaccharidosis, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia. Address: 500 Collins Street, Melbourne, VIC, Australia, 3000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service